WHO Alert For Indian Drug, 5th In 10 Months: 'Jan Vishwas', The Law We Need?
Listen now
Description
This week, the WHO flagged a contaminated Indian-made cough syrup in Iraq - the 5th such warning against medicine produced in India by the organization in 10 months. While the government cracked down on over 70 firms back in March, substandard drugs continue to be manufactured in India and sold across domestically and worldwide - prompting worry about the currently existing drug regulation norms in the country. Amid all this, Parliament passed the Jan Vishwas Bill earlier this month, which arguably hands a 'get out of jail free' card to pharma companies. On We The People, we ask - how urgent is the need for a unified drug regulation law in India?
More Episodes
Global pharma giant AstraZeneca has admitted that its COVID-19 vaccine developed by researchers from Oxford University and manufactured by the Serum Institute of India can cause a rare side effect of blood clotting and low platelet count. AstraZeneca said this in a statement responding to a class...
Published 05/05/24
Published 05/05/24
Singapore and Hong Kong have taken off Everest and MDH masalas from their shelves, citing food safety concerns. It's not just masals, Cerelac was in the dock after a report suggested that Nestle adds sugar only to baby food in India. Also, Bournvita is no longer categorised as a 'health drink....
Published 04/28/24